Positive results for new HCM drug
22nd May 2020
Read about the latest developments regarding the drug Mavacamten.
Latest news
Category: Research
New drug called Dapagliflozin available for heart failure patients
9th September 2019
For heart failure patients there could soon be another new drug available alongside Entresto, called Dapagliflozin. This new drug will help people not only live longer and avoid hospitalisation but more importantly feel better within themselves. Read the full article here.
How 30 years of medical progress has helped our understanding
28th July 2019
Dr Antonis Pantazis and Samantha Mason discuss the past 30 years of medical process and what the future holds for research and treatment into heart muscle diseases. This article was taken from our May edition of My Life.
Pregabalin and Gabapentin – Reclassification of Class C Controlled Drugs
20th March 2019
From 1st April 2019, the drugs pregabalin and gabapentin will be reclassified as class C controlled drugs in the UK. It is important to be aware of how these changes will affect prescribing and dispensing processes. Read more here.
Brain clue to Takotsubo cardiomyopathy
5th March 2019
Swiss researchers reveal a potential link between Takotsubo cardiomyopathy and raised levels of stress hormones, such as adrenaline. Read more here.
Faulty 'brake' interferes with heart muscle's ability to contract and relax
4th March 2019
A new study has pinpointed a faulty molecular brake present in the most common form of hypertrophic cardiomyopathy (HCM) and has identified a candidate compound that restores heart muscle function in human and mouse cells. Read more about the study here.
Study identifies clinical risks and biomarkers that could be used to screen patients with heart condition
8th January 2019
Researchers have identified two biomarkers that could help in the diagnosis of a heart condition that raises the risk of stroke. Read about the study here.
New Study Exposes Danger of Stopping Drug Treatment for Dilated Cardiomyopathy (DCM)
16th November 2018
New study finds that for those participants who withdrew treatment for DCM, 40% experienced a re-emergence of symptoms, after just eight weeks of withdrawal. Read on to find out more.
Men with dilated cardiomyopathy are more likely to die than women
14th June 2018
A new study published in the Journal of the American College of Cardiology shows that men are 64 percent more likely to die from dilated cardiomyopathy (DCM) than women.
Researcher looking for newly diagnosed experiences of cardiomyopathy
18th January 2018
PHD Researcher Jennifer Rees is looking for newly diagnosed experiences of cardiomyopathy and wants to hear from you!
